Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology

被引:27
|
作者
Zehbe, Ingeborg [1 ,2 ,3 ]
Jackson, Robert [1 ,4 ]
Wood, Brianne [5 ]
Weaver, Bruce [3 ]
Escott, Nicholas [3 ,6 ]
Severini, Alberto [7 ]
Krajden, Mel [8 ]
Bishop, Lisa [2 ]
Morrisseau, Kyla [2 ]
Ogilvie, Gina [8 ,9 ]
Burchell, Ann N. [10 ,11 ]
Little, Julian [5 ]
机构
[1] Thunder Bay Reg Res Inst, Probe Dev & Biomarker Explorat, Thunder Bay, ON, Canada
[2] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada
[3] Northern Ontario Sch Med, Clin Sci, Thunder Bay, ON, Canada
[4] Lakehead Univ, Biotechnol Program, Thunder Bay, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Thunder Bay Reg Hlth Sci Ctr, Dept Pathol & Lab Med, Thunder Bay, ON, Canada
[7] Publ Hlth Agcy Canada, Viral Exanthemata & STD Sect, Natl Microbiol Lab, Winnipeg, MB, Canada
[8] BC Ctr Dis Control, Vancouver, BC, Canada
[9] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada
[10] Ontario HIV Treatment Network, Toronto, ON, Canada
[11] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
来源
BMJ OPEN | 2016年 / 6卷 / 10期
基金
加拿大健康研究院;
关键词
TO-TREAT ANALYSIS; 1ST NATIONS; NEW-ZEALAND; WOMEN; HPV; STATEMENT; CANADA; INTERVENTION; INDIVIDUALS; AUSTRALIA;
D O I
10.1136/bmjopen-2016-011754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The incidence of cervical cancer is up to 20-fold higher among First Nations women in Canada than the general population, probably due to lower participation in screening. Offering human papillomavirus (HPV) self-sampling in place of Papanicolaou (Pap) testing may eventually increase screening participation and reduce cervical cancer rates in this population. Design: A community-randomised controlled screening trial. Setting: First Nations communities in Northwest Ontario, Canada. Participants: Women aged between 25 and 69, living in Robinson Superior Treaty First Nations. The community was the unit of randomisation. Interventions: Women were asked to complete a questionnaire and have screening by HPV self-sampling (arm A) or Pap testing (arm B). Primary outcome measures: The number of women who participated in cervical screening. Randomisation: Community clusters were randomised to include approximately equivalent numbers of women in each arm. Results: 6 communities were randomised to arm A and 5 to arm B. One community withdrew, leaving 5 communities in each group (834 eligible women). Participation was <25%. Using clustered intention-to-treat (ITT) analysis, initial and cumulative averaged uptakes in arm A were 1.4-fold (20% vs 14.3%, p=0.628) and 1.3-fold (20.6% vs 16%, p=0.694) higher compared to arm B, respectively. Corresponding per protocol (PP) analysis indicates 2.2-fold (22.9% vs 10.6%, p=0.305) and 1.6-fold (22.9% vs 14.1%, p=0.448) higher uptakes in arm A compared to arm B. Screening uptake varied between communities (range 0-62.1%). Among women who completed a questionnaire (18.3% in arm A, 21.7% in arm B), the screening uptake was 1.8-fold (ITT; p=0.1132) or 3-fold (PP; p<0.01) higher in arm A versus arm B. Conclusions: Pap and HPV self-sampling were compared in a marginalised, Canadian population. Results indicated a preference for self-sampling. More research on how to reach underscreened Indigenous women is necessary.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] THE SENSITIVITY AND SPECIFICITY OF HUMAN PAPILLOMA VIRUS SELF-SAMPLING COLLECTION TEST IN CERVICAL CYTOLOGY SCREENING
    Masadah, R.
    Chandra, R.
    Rauf, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 402 - 402
  • [42] Women's perspectives on human papillomavirus self-sampling in the context of the UK cervical screening programme
    Williams, Denitza
    Davies, Myfanwy
    Fiander, Alison
    Farewell, Daniel
    Hillier, Sharon
    Brain, Kate
    HEALTH EXPECTATIONS, 2017, 20 (05) : 1031 - 1040
  • [43] HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
    Aasbo, Gunvor
    Trope, Ameli
    Nygard, Mari
    Christiansen, Irene Kraus
    Baasland, Ingrid
    Iversen, Grete Alrek
    Munk, Ane Cecilie
    Christiansen, Marit Halonen
    Presthus, Gro Kummeneje
    Undem, Karina
    Bjorge, Tone
    Castle, Philip E.
    Hansen, Bo T.
    BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1816 - 1826
  • [44] To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed
    Charlebois, Shannon
    Kean, Sarah
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (21) : E729 - E730
  • [45] HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: a pragmatic randomised controlled trial
    Gunvor Aasbø
    Ameli Tropè
    Mari Nygård
    Irene Kraus Christiansen
    Ingrid Baasland
    Grete Alrek Iversen
    Ane Cecilie Munk
    Marit Halonen Christiansen
    Gro Kummeneje Presthus
    Karina Undem
    Tone Bjørge
    Philip E. Castle
    Bo T. Hansen
    British Journal of Cancer, 2022, 127 : 1816 - 1826
  • [46] Design of a pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake in a US healthcare system: The STEP trial
    Winer, Rachel L.
    Lin, John
    Anderson, Melissa L.
    Tiro, Jasmin A.
    Meenan, Richard T.
    Hansen, Kristina
    Gao, Hongyuan
    Sparks, Angela
    Greene, Dina N.
    Kilgore-Martin, Sony
    Green, Beverly B.
    Buist, Diana S. M.
    CONTEMPORARY CLINICAL TRIALS, 2022, 122
  • [47] Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial
    Kobetz, Erin
    Seay, Julia
    Amofah, Anthony
    Pierre, Larry
    Bispo, Jordan Baeker
    Trevil, Dinah
    Gonzalez, Martha
    Poitevien, Martine
    Koru-Sengul, Tulay
    Carrasquillo, Olveen
    TRIALS, 2017, 18
  • [48] Mailed HPV self-sampling for cervical cancer screening among underserved minority women: study protocol for a randomized controlled trial
    Erin Kobetz
    Julia Seay
    Anthony Amofah
    Larry Pierre
    Jordan Baeker Bispo
    Dinah Trevil
    Martha Gonzalez
    Martine Poitevien
    Tulay Koru-Sengul
    Olveen Carrasquillo
    Trials, 18
  • [49] Impact of university students’ awareness and attitudes on vaccination practices for human papillomavirus, and perception on self-sampling for cervical cancer screening
    Mathumalar Loganathan Fahrni
    Muhamad Zabidi Azni
    Nurhani Syafiqah Mohd Rusdi
    Chee-Yan Choo
    Khairil Anuar Md Isa
    Zaheer-Ud-Din Babar
    Journal of Pharmaceutical Policy and Practice, 15
  • [50] Evaluation of a novel vaginal cells self-sampling device for human papillomavirus testing in cervical cancer screening: A clinical trial assessing reliability and acceptability
    Yang, Chung-Yao
    Chang, Ting-Chang
    Chou, Hung-Hsueh
    Chao, Angel
    Hsu, Shih-Tien
    Shih, Yu-Hsiang
    Huang, Huei-Jean
    Lin, Cheng-Tao
    Chen, Min-Yu
    Sun, Lou
    Huang, Kuan-Gen
    Wu, Kai-Yun
    Hsieh, Wu-Chiao
    Huang, Yi-Ting
    Chen, Liang-Hsuan
    Lu, Chien-Hsing
    Lin, Hao
    Cheng, Chao-Min
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2024, 9 (04)